Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune (Idiopathic) Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05328804
What this trial is testing

Herombopag + rhTPO in Severe Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Yin Jie 90
Post-approval studies (Phase 4)Study completedNCT01098487
What this trial is testing

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 167
Testing effectiveness (Phase 2)WithdrawnNCT01976195
What this trial is testing

High-dose Dexamethasone Combining Thalidomide Versus Dexamethasone Mono-therapy for Management of Newly-diagnosed ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University
Early research (Phase 1)Not Yet RecruitingNCT07315373
What this trial is testing

Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07687134
What this trial is testing

Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP

Who this might be right for
Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 40
Post-approval studies (Phase 4)UnknownNCT05522465
What this trial is testing

Short-course High-dose Prednisone and Dexamethasone in Children With ITP

Who this might be right for
Immune ThrombocytopeniaGlucocorticoidsChild, Only
Fujian Medical University Union Hospital 608
Not applicableStudy completedNCT01933035
What this trial is testing

Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.

Who this might be right for
Immune ThrombocytopeniaChemotherapy Induced ThrombocytopeniaMyelodysplasia+1 more
Beth Israel Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Large-scale testing (Phase 3)Study completedNCT00770562
What this trial is testing

A Study Evaluating the Addition of MabThera (Rituximab) to Standard Treatment in Patients With Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 103
Post-approval studies (Phase 4)Looking for participantsNCT04518475
What this trial is testing

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 224
Large-scale testing (Phase 3)Study completedNCT00376077
What this trial is testing

Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP.

Who this might be right for
Immune Thrombocytopenic Purpura
The Hospital for Sick Children 32
Testing effectiveness (Phase 2)UnknownNCT05333744
What this trial is testing

The Combination of Prednisone and Recombinant Human Thrombopoietin for Treatment of Immune Thrombocytopenia in Pregnancy

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT07362199
What this trial is testing

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 20
Large-scale testing (Phase 3)Study completedNCT00344149
What this trial is testing

Rituximab as Second Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenia (ITP)
Ostfold Hospital Trust 112
Testing effectiveness (Phase 2)UnknownNCT04289207
What this trial is testing

Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Seoul National University Hospital 55
Testing effectiveness (Phase 2)Study completedNCT00902018
What this trial is testing

Eltrombopag and the Bcl-extra-large (xL) Pathway in Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Immune Thrombocytopenia
Weill Medical College of Cornell University 20
Not applicableUnknownNCT03123497
What this trial is testing

Assessment of Quality of Life of Children With Chronic Idiopathic Thrombocytopenic Purpura (Kid's ITP Tools)

Who this might be right for
Idiopathic Thrombocytopenic Purpura
University Hospital, Angers 183
Not applicableStudy completedNCT03219723
What this trial is testing

Drug Use Surveillance of Takecab for "Supplement to Helicobacter Pylori Eradication"

Who this might be right for
Gastric/Duodenal Ulcer, Gastric MALT Lymphoma, Idiopathic Thrombocytopenic Purpura, or H. Pylori Gastritis, and Other
Takeda 560
Large-scale testing (Phase 3)Study completedNCT00828750
What this trial is testing

Clinical Evaluation of Eltrombopag in Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
GlaxoSmithKline 19
Testing effectiveness (Phase 2)Study completedNCT00049725
What this trial is testing

Daclizumab to Treat Chronic Immune Thrombocytopenia

Who this might be right for
Thrombocytopenia
National Institutes of Health Clinical Center (CC) 24
Next Page